Advertisement
IMTH
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IMTH’s FA Score shows that 1 FA rating(s) are green while.
- IMTH’s FA Score: 1 green, 4 red.
Price Growth
IMTH (@Medical Specialties) experienced а -13.35% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.06%. For the same industry, the average monthly price growth was +2.33%, and the average quarterly price growth was -2.29%.
Reported Earning Dates
IMTH is expected to report earnings on May 20, 2025.
Industries' Descriptions
@Medical Specialties (+1.06% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| IMTH | |
| Capitalization | 5.29M |
| EBITDA | -20.14M |
| Gain YTD | -7.941 |
| P/E Ratio | N/A |
| Revenue | 1.64M |
| Total Cash | 194K |
| Total Debt | 2.2M |
IMTH | ||
|---|---|---|
OUTLOOK RATING 1..100 | 61 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 23 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 53 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | 30 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
Advertisement
IMTH and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, IMTH has been loosely correlated with CYBQF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTH jumps, then CYBQF could also see price increases.
| Ticker / NAME | Correlation To IMTH | 1D Price Change % | ||
|---|---|---|---|---|
| IMTH | 100% | -13.35% | ||
| CYBQF - IMTH | 41% Loosely correlated | N/A | ||
| YBGJ - IMTH | 13% Poorly correlated | -25.37% | ||
| KSRBF - IMTH | 13% Poorly correlated | N/A | ||
| MASS - IMTH | 7% Poorly correlated | -2.91% | ||
| ASAPF - IMTH | 4% Poorly correlated | +1.10% | ||
More | ||||